Dogwood Therapeutics, Inc. Number of Reportable Segments
Dogwood Therapeutics, Inc. (DWTX) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-14
- Dogwood Therapeutics, Inc. number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- Dogwood Therapeutics, Inc. number of reportable segments for the quarter ending 2025-03-31 was 1.00 segment.
- Dogwood Therapeutics, Inc. number of reportable segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- Dogwood Therapeutics, Inc. number of reportable segments for fiscal 2024 was 1.00 segment.
- Dogwood Therapeutics, Inc. number of reportable segments for fiscal 2021 was 1.00 segment.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-03-18 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-13 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-09 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-03-31 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |